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Abstract  
BACKGROUND: One of the main factors affecting male infertility is DNA fragmentation in sperm. Male infertility is 
a heterogeneous group of disorders, known causes account for only 30-50%, and unknown cause (idiopathic) 
constitute the rest. Infertility involves nearly 15% of couples in the reproductive age, and only the male problem 
involves about 40% of the problems. 
AIM: We have studied our DNA damage to sperm cells of a group of infertile males (113 patients) with abnormal 
sperm parameters (oligoasthenospermia and oligospermia) and a group of male patients (80 patients) with normal 
semen parameters (normospermia) to document whether the Sperm Chromatin Dispersion (SCD) analysis could 
increase the information obtained from the sperm routine analysis to explain the causes of infertility. 
MATERIALS: A group of 193 patients were analysed, 113 patients in the working group and 80 patients in the 
control group were screened. The ejaculate samples were taken by the patient to whom the reason for the 
analysis was explained. All patients were from the Republic of Kosovo. Samples are collected from 2014/2018. 
Sperm Chromatin Dispersion (SCD) analyses in the ejaculate were analysed by the Biolab Zafi laboratory in Peja.  
RESULTS: Clinical data were compared between the two groups by one-way ANOVA, mean ± SD, student's t-
test. A p-value of less than P < 0.05% was considered statistically significant. Outcomes: In our study, we have 
gained significant (P < 0.05) results in the workgroup and the control group across all hormonal parameters, 
sperm parameters, and fragmented DNA in the sperm.  
CONCLUSION: Based on our obtained results we can conclude that DNA fragmentation in spermatozoa is useful 
in the selection of unsuitable DNA sperm for use in ART methods. We conclude that our DNA fragmentation 
analysis results are encouraging and can be used for diagnostic purposes in determining male infertility. 
 
 
 
 
 
 
Introduction 
 
Male-factor infertility reportedly accounts for 
30–40% of cases of couple infertility. Infertility is 
defined as the inability to achieve a successful 
pregnancy after 12 months of unprotected intercourse 
or therapeutic donor insemination (Practice 
Committee of the American Society for Reproductive 
Medicine, 2013) [1]. The natural desire of human 
beings is to propagate their lineage and is part and 
parcel of human evolution. The inability to conceive 
and produce a pregnancy results in the depression in 
couples. This infertility or subfertility forces couples to 
seek a solution as the problem results in social 
stigma. One in eight couples encounters problems 
when attempting to conceive a first child and one in 
six when attempting to conceive a subsequent child. 
Three per cent of women remains involuntarily 
childless, while 6% of parous women are not able to 
have as many children as they would wish [2]. Male 
fertility can be reduced as a result of congenital or 
acquired urogenital abnormalities, malignancies, 
urogenital tract infections, increased scrotal 
temperature (e.g. as a consequence of varicocele), 
endocrine disturbances, genetic abnormalities and 
immunological factors [2]. In about 15% of infertile 
male subjects, genetic abnormalities may be present, 
including chromosome aberrations and single gene 
mutations [3]. The cause of infertility can be attributed 
to male, female or due to both the partners and in a 
significant number the cause of infertility is 
unexplained. Hence simultaneous evaluation of both 
male and female partners of the infertile couple should 
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be done. Appropriate investigative modalities and the 
proper assisted reproductive procedure adopted will 
bring a definitive change in partners affected by 
infertility. Affected male partner of infertile couples 
should undergo semen analysis as a primary 
procedure. When the male partner alone is involved in 
infertility, it can save time and procedures can be 
accelerated which is also less expensive. One of the 
main factors affecting male infertility is DNA 
fragmentation in the sperm.  
Male infertility is a heterogeneous group of 
disorders, the known causes account for only 30-50%, 
and the unknown cause (idiopathic) is the rest of 
infertility. It is of great importance to consider the 
effects of DNA damage on the sperm because half of 
the DNA in the progeny comes from the father's unit 
[4]. As a consequence of the complex anatomical and 
functional integration of the reproductive system, 
spermatogenesis in the germinal epithelium and the 
regulatory role of the hypothalamohypophysial-
testicular axis are very susceptible; their changes 
become apparent even in the deterioration of fertility 
[5]. The hormone responsible for spermatogenesis is 
LH [6]. This glycoprotein regulates the testosterone 
synthesis of the extra tubular Leydig cells. FSH 
controls spermatogenesis by affecting both the 
germinal epithelium and Sertoli cells [7]. 
 However, LH secretion is regulated by the 
negative feedback of the testosterone in the vascular 
system. The serum LH concentration reflects the 
function of Leydig cells; it is an important factor in the 
differential diagnosis between primary sociopathy and 
hypothalamo-hypophyseal hormone deficient [8]. 
Despite some deficiencies, spermogram analysis is 
generally acceptable and is considered reliable in 
evaluating male fertility [9]. Spermogram analysis 
does not always indicate the quality and sperm health 
[10]. For the accurate disclosure of genetic 
information, the integrity of the DNA molecule is 
essential [11].  
The main causes of early pregnancy loss are 
genetic abnormalities in the sperm genome (EPL) 
[12]. Independent fertility indicators in couples subject 
to ART can be used for DFI [13]. The diagnostic test 
used today (SCD) is a lightweight and fast test based 
on the sperm chromatin dispersion [14]. Normal 
sperm creates DNA halo zones [15]. It has been 
established that if sperm DNA fragmentation exceeds 
30%, sperm quality is significantly reduced [16]. 
Based on the percentage of DNA fragmentation, it is 
possible to choose the right technique in assisted 
medical care clinics. Patient selection based on sperm 
parameters to perform DNA fragmentation analysis is 
advisable.  
We have studied our DNA damage to sperm 
cells of a group of infertile males (113 patients) with 
abnormal sperm parameters (oligoasthenospermia 
and oligospermia) and a group of male patients (80 
patients) with normal semen parameters 
(normospermia) to document whether the Sperm 
Chromatin Dispersion (SCD) analysis could increase 
the information obtained from the sperm routine 
analysis to explain the causes of infertility.  
 
 
Materials and Methods  
 
There were analysed 193 patients, 113 
patients in the working group and 80 patients in the 
control group. Patients received for analysis were all 
from the Republic of Kosovo. The sampling period 
was 2014/2018. All analyses were performed at 
Biolab Zafi, Laboratory in Peja. 
Sperm analysis was done according to World 
Health Organization guidelines (WHO, 2010) [17]. 
 
Figure 1: Sperm DNA fragmentation kit 
 
Analysis of hormone levels of FSH, LH, 
prolactin, testosterone, will be made by ECIA (Eng. 
electrochemiluminescence immunoassay) in a mini 
VIDAS ® (bioMérieux, Marcy l'Etoile, France), in the 
laboratory clinic "BIOLAB-Zafi" Peja, R. of Kosovo.  
Clinical data were compared between the two 
groups by one-way ANOVA, mean ± SD, student's t-
test. A p-value of less than p < 0.05% was considered 
statistically significant. 
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Results  
 
From the results obtained after analysing and 
comparing hormonal parameters in both groups of 
patients to take analysis (working group and group 
control) received the following results. 
Table 1: Table presentation of the two groups of patients taken 
for analysis 
 Infertility group 
(113 patients) 
Average/Std 
Fertile group (80 
patients) 
Average/Std 
t-test Significant 
P < 0.05 
FSH 10.35 ± 8.17 6.42 ± 4.12 4.748 p<0.00001 
LH 8.14 ± 4.96 4.98 ± 3.15 2.759 p<0.01 
Prolactin  16.56 ± 4.61 10.29 ± 8.97 3.543 p<0.00001 
Testosterone  2.85 ± 1.78 5.46 ± 3.76 2.754 p<0.001 
Number in 1 million 
sperm 
19.67 ± 19.79 61.43 ± 34.47 -8.247 p<0.00001 
The general moving 28.29 ± 18.37 57.15 ± 10.83 -10.151 p<0.00001 
Movement A 14.09 ± 10.86 25.21 ± 7.46 -7.359 p<0.00001 
Movement B+C 14.03 ± 10.88 31.73 ± 10.09 -9.928 p<0.00001 
Without moving 71.59 ± 18.34 42.7 ± 10.9 11.554 p<0.00001 
Normal morphology  16.90 ± 14.47 42.6 ± 15.2 -9.696 p<0.00001 
Abnormal 
morphology  
83.09 ± 14.47 57.2 ± 16.2 8.991 p<0.00001 
DNA- fragmentation 
(SDF%) 
34.53 ± 4.68 14.91 ± 4.02 11.476 p<0.00001 
 
The Table 1, shows that all hormones (FSH, 
LH, prolactin, and testosterone) defined in patients 
with infertility are at the significantly higher (p < 0.05) 
degree compared with hormones designated the 
control group. 
 
Figure 2: Graphical presentation of Sperm DNA Fragmentation (%) 
 
In our work, we have gained significant results 
between the working group and control group on all 
spermogram parameters (p < 0.001001), and in DNA 
fragmentation in the sperm (p < 0.001001). 
 
Figure 3: Graphical presentation of sperm parameters between two 
groups of patients taken for analysis 
 
 
 
Discussion  
 
The FSH, LH and testosterone evaluation is 
useful in the management of male infertility. FSH is 
necessary for initiation of spermatogenesis and 
maturation of spermatozoa [18]. In infertile men, a 
higher concentration of FSH is considered to be a 
reliable indicator of germinal epithelial damage, and 
was shown to be associated with severe 
oligozoospermia [19] [20] and reported that elevated 
levels of serum FSH with increasing severity of 
seminiferous epithelial destruction.  
 
Figure 4: Photo by microscope during Sperm DNA Fragmentation 
analysis 
 
However, FSH acts directly on the 
seminiferous tubules whereas LH stimulates 
spermatogenesis indirectly via testosterone. FSH 
plays a key role in stimulating mitotic and meiotic DNA 
synthesis in spermatogonia [21]. The increase in 
serum levels of gonadotropins might have disrupted 
the spermatogenic process leading to the decline in 
the sperm count and infertility [22]. In the present 
study, elevated serum levels of FSH and LH were 
observed in oligozoospermia and asthenozoospermia 
males when compared with normozoospermic men 
[23]. Also found that the high values of FSH, LH, 
Testosterone affect the reduction of sperm 
parameters [24]. 
From this paper, we have gained higher 
percentages of DNA than fragmented into infertile male 
sperm that had abnormal morphology and decreased 
mobility. Our results are consistent with the studies 
(Sergerie et al., 2005) [25] that found a DFI in the 
infertility group was significantly higher than in the 
fertile group (40.9 ± 14.3% compared to 13.1 ± 7.3%) 
and the mean sperm concentration in the infertile group 
was also significantly lower compared to the fertile 
group (62.9 ± 33.2 × 10
6
/ml compared to 102.4 ± 66.4 
× 10
6
/ml). DFI can be used to distinguish infertile men 
from fertile men [26]. A man with DFI sperm ≥ 26.1% 
has 2.84 times higher risk for infertility than the male 
with DFI sperm of < 26.1%. 
In conclusion, determining Hormones (FSH, 
LH, Prolactin, Testosterone) of infertile men is a major 
step towards predicting infertility. Results of hormonal 
analysis and sperm parameters serve as an indicator 
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for medical personnel to determine male infertility. 
From our original work, we can conclude that with the 
increase of hormone parameters there is a reduction 
of sperm parameters (total number, total movement, 
movement A, movement B, normal form, abnormal 
form) and reduction of male reproductive capacity. We 
have concluded in our paper that there is a negative 
correlation between DNA fragmentation, mobility and 
morphology of sperm in male infertile. Based on our 
obtained results we can conclude that DNA 
fragmentation in spermatozoa is useful in the 
selection of unsuitable DNA sperm for use in ART 
methods. We conclude that our DNA fragmentation 
analysis results are encouraging and can be used for 
diagnostic purposes in determining male infertility. 
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